These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 28976544)
1. Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy. Truong M; Wang B; Gordetsky JB; Nix JW; Frye TP; Messing EM; Thomas JV; Feng C; Rais-Bahrami S Cancer; 2018 Jan; 124(2):278-285. PubMed ID: 28976544 [TBL] [Abstract][Full Text] [Related]
2. Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram. Bjurlin MA; Renson A; Rais-Bahrami S; Truong M; Rosenkrantz AB; Huang R; Taneja SS Eur Urol Focus; 2019 Sep; 5(5):815-822. PubMed ID: 29802053 [TBL] [Abstract][Full Text] [Related]
3. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3? Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884 [TBL] [Abstract][Full Text] [Related]
4. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans. Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990 [TBL] [Abstract][Full Text] [Related]
5. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies. Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169 [TBL] [Abstract][Full Text] [Related]
6. Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml? Xu N; Wu YP; Chen DN; Ke ZB; Cai H; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY J Cancer Res Clin Oncol; 2018 May; 144(5):987-995. PubMed ID: 29504080 [TBL] [Abstract][Full Text] [Related]
7. A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer. Wagaskar VG; Sobotka S; Ratnani P; Young J; Lantz A; Parekh S; Falagario UG; Li L; Lewis S; Haines K; Punnen S; Wiklund P; Tewari A Cancer Rep (Hoboken); 2021 Aug; 4(4):e1357. PubMed ID: 33661541 [TBL] [Abstract][Full Text] [Related]
8. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen. Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370 [TBL] [Abstract][Full Text] [Related]
9. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844 [TBL] [Abstract][Full Text] [Related]
10. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region. Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557 [TBL] [Abstract][Full Text] [Related]
11. [Developing a Chinese PI-RADS v2-based nomogram for predicting clinically significant prostate cancer in patients with a prior negative biopsy]. Huang C; Song G; Wang H; Ji GJ; Chen YK; He Q; Zhou LQ Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2559-2563. PubMed ID: 30220139 [No Abstract] [Full Text] [Related]
12. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747 [TBL] [Abstract][Full Text] [Related]
13. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer. Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182 [TBL] [Abstract][Full Text] [Related]
14. MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy. Huang C; Song G; Wang H; Ji G; Li J; Chen Y; Fan Y; Fang D; Xiong G; Xin Z; Zhou L Biomed Res Int; 2018; 2018():6368309. PubMed ID: 30276213 [TBL] [Abstract][Full Text] [Related]
15. Are prostate biopsies necessary for all patients 75years and older? Chen Y; Fan Y; Yang Y; Jin J; Zhou L; He Z; Zhao Z; He Q; Wang X; Yu W; Wu S J Geriatr Oncol; 2018 Mar; 9(2):124-129. PubMed ID: 28939384 [TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
17. A SelectMDx/magnetic resonance imaging-based nomogram to diagnose prostate cancer. Wagaskar VG; Levy M; Ratnani P; Sullimada S; Gerenia M; Schlussel K; Choudhury S; Gabriele M; Haas I; Haines K; Tewari A Cancer Rep (Hoboken); 2023 Jan; 6(1):e1668. PubMed ID: 36168681 [TBL] [Abstract][Full Text] [Related]
18. Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary? Wang RS; Kim EH; Vetter JM; Fowler KJ; Shetty AS; Mintz AJ; Badhiwala NG; Grubb RL; Andriole GL Urology; 2017 Apr; 102():190-197. PubMed ID: 27845218 [TBL] [Abstract][Full Text] [Related]
19. Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort. Patel HD; Koehne EL; Shea SM; Bhanji Y; Gerena M; Gorbonos A; Quek ML; Flanigan RC; Goldberg A; Gupta GN Cancer; 2022 Jan; 128(1):75-84. PubMed ID: 34427930 [TBL] [Abstract][Full Text] [Related]
20. Nomogram predicting prostate cancer in patients with negative prebiopsy multiparametric magnetic resonance. Chen M; Wang R; Zhang T; Zhang X; Wan Y; Fu X Future Oncol; 2022 Apr; 18(12):1473-1483. PubMed ID: 35105154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]